52U Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Hyloris Pharmaceuticals SA

Watchlist Manager

Watchlist

Price: 3.88 EUR 2.37%

Market Cap: €108.6m

	Hyloris Pharmaceuticals SA F:52U	BE
A	AmperCap Acquisition Co NASDAQ:APMC	US
	Lotus Bakeries NV F:7LB	BE
	Warehouses Estates Belgium SA F:WPK	BE
	Bosideng International Holdings Ltd F:3BD	HK
O	Orange Belgium NV XMUN:MOS	BE
B	BioLASCO Taiwan Co Ltd TPEX:6662	TW
O	Orange Belgium NV DUS:MOS	BE
	Melexis NV F:MEX	BE
C	Care Property Invest NV F:8OM	BE
	Lode Resources Ltd OTC:LDRLF	AU

Profitability Summary

Hyloris Pharmaceuticals SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

96%

Gross Margin is Increasing

91% > 95%

Negative Operating Margin

-107%

Negative 3Y Average Operating Margin

-254%

Operating Margin is Increasing

-1 157% > -107%

Negative Net Margin

-88%

Negative 3Y Average Net Margin

-246%

Net Margin is Increasing

-1 158% > -88%

Negative Free Cash Flow Margin

-106%

Negative 3Y Average Free Cash Flow Margin

-240%

Free Cash Flow Margin is Increasing

-762% > -106%

Negative ROE

-22%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-82%

ROIC is Increasing

-130% > -52%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.